1. Cross-talk between myeloid-derived suppressor cells and Mucin1 in breast cancer vaccination: On the verge of a breakthrough
   Mahdi Abdoli Shadbad et al, 2020, Life Sciences CrossRef
2. Mucin 1 promotes salivary gland cancer cell proliferation and metastasis by regulating the epidermal growth factor receptor signaling pathway
   Hao Lu et al, 2023, Journal of Dental Sciences CrossRef
3. Neuraminidase 1 regulates proliferation, apoptosis and the expression of Cadherins in mammary carcinoma cells
   Padmamalini Thulasiraman et al, 2019, Molecular and Cellular Biochemistry CrossRef
4. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
   Xianglan Yi et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef
5. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets
   Kishore Banik et al, 2019, Pharmacological Research CrossRef
6. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
   Quan Gao et al, 2022, Advanced Drug Delivery Reviews CrossRef
7. Microstructured Optical Fiber-Enhanced Light–Matter Interaction Enables Highly Sensitive Exosome-Based Liquid Biopsy of Breast Cancer
   Zihao Liu et al, 2023, Analytical Chemistry CrossRef
8. Miniaturized Laser Probe for Exosome-Based Cancer Liquid Biopsy
   Mingqian Suo et al, 2024, Analytical Chemistry CrossRef
9. Anti–MUC1 nanobody can synergize the Tamoxifen and Herceptin effects on breast cancer cells by inducing ER, PR and HER2 overexpression
   Mahdieh Shokrollahi Barough et al, 2023, International Immunopharmacology CrossRef
10. Honokiol: A review of its pharmacological potential and therapeutic insights
    Abdur Rauf et al, 2021, Phytomedicine CrossRef
11. Therapeutic Potential of the Natural Compound S-Adenosylmethionine as a Chemoprotective Synergistic Agent in Breast, and Head and Neck Cancer Treatment: Current Status of Research
    Laura Mosca et al, 2020, International Journal of Molecular Sciences CrossRef
12. Bioinformatics and In Vitro Study Reveal ERα as The Potential Target Gene of Honokiol to Enhance Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant Breast Cancer Cells
    I Made Rhamanadana Putra et al, 2024, Computational Biology and Chemistry CrossRef